XML 38 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenues        
Product sales, net $ 5,699,000 $ 6,236,000
Royalty revenue 126,000 $ 5,000 1,776,000 $ 1,951,000
Collaborative and other research and development 5,162,000 3,233,000 35,643,000 6,211,000
Total revenues 10,987,000 $ 3,238,000 43,655,000 $ 8,162,000
Expenses        
Cost of products sold 1,346,000 1,361,000
Research and development 20,067,000 $ 13,036,000 53,711,000 $ 33,286,000
Selling, general and administrative 2,731,000 $ 1,812,000 10,326,000 5,413,000
Royalty 5,000 507,000 78,000
Total operating expenses 24,149,000 $ 14,848,000 65,905,000 38,777,000
Loss from operations (13,162,000) (11,610,000) (22,250,000) (30,615,000)
Interest and other income 134,000 14,000 367,000 50,000
Interest expense (1,241,000) (1,217,000) (3,862,000) (3,684,000)
(Loss) gain on foreign currency derivative (352,000) 4,082,000 861,000 732,000
Net loss $ (14,621,000) $ (8,731,000) $ (24,884,000) $ (33,517,000)
Basic and diluted net loss per common share (in dollars per share) $ (0.20) $ (0.12) $ (0.34) $ (0.52)
Weighted average shares outstanding (in shares) 73,262 71,801 72,752 65,057
Unrealized gain (loss) on available for sale investments $ 91,000 $ (1,000) $ 129,000 $ (2,000)
Comprehensive loss $ (14,530,000) $ (8,732,000) $ (24,755,000) $ (33,519,000)